Cargando…
The brain-penetrant cell-cycle inhibitor p28 sensitizes brain metastases to DNA-damaging agents
BACKGROUND: Brain metastases (BMs), the most common tumors of the central nervous system, are life-threatening with a dismal prognosis. The major challenges to developing effective treatments for BMs are the limited abilities of drugs to target tumors and to cross the blood-brain barrier (BBB). We a...
Autores principales: | Mander, Sunam, Gorman, Gregory S, Coward, Lori U, Christov, Konstantin, Green, Albert, Das Gupta, Tapas K, Yamada, Tohru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184511/ https://www.ncbi.nlm.nih.gov/pubmed/37197737 http://dx.doi.org/10.1093/noajnl/vdad042 |
Ejemplares similares
-
Tumor-targeting cell-penetrating peptide, p28, for glioblastoma imaging and therapy
por: Mander, Sunam, et al.
Publicado: (2022) -
A brain-penetrant microtubule-targeting agent that disrupts hallmarks of glioma tumorigenesis
por: Horne, Eric A, et al.
Publicado: (2020) -
VCAM-1 targeted alpha-particle therapy for early brain metastases
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2020) -
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases
por: Griguolo, Gaia, et al.
Publicado: (2022) -
Growth dynamics of brain metastases differentiate radiation necrosis from recurrence
por: Ocaña-Tienda, Beatriz, et al.
Publicado: (2022)